Dr. Agada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12750 Horseferry Rd
Ste 100
Carmel, IN 46032Phone+1 317-795-0707Fax+1 317-795-0706
Summary
- Dr. Noah Agada is an allergist/immunologist in Carmel, IN and is affiliated with multiple hospitals in the area, including St. Vincent Carmel Hospital, Community Hospital North, and Community Hospital South. He completed Pediatric Residency at Dayton Children's Hospital and a Fellowship in Allergy & Immunology at Duke University Medical Center. He has been in practice 27 years. He specializes in pediatric and adult asthma & allergic conditions.
Education & Training
- Duke University HospitalFellowship, Allergy and Immunology, 2013 - 2015
- Wright State UniversityResidency, Pediatrics, 2010 - 2013
- Johns Hopkins UniversityMPH, Public Health, 2008 - 2009
- University of IbadanMSc, Chemical Pathology, 2000 - 2002
- University of Jos Faculty of MedicineClass of 1990
Certifications & Licensure
- DC State Medical License 2024 - 2026
- IN State Medical License 2015 - 2025
- NC State Medical License 2013 - 2025
- OH State Medical License 2010 - 2013
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 4 citationsChanges in health-related quality of life and associations with improvements in clinical efficacy: a Phase 2 study of mirikizumab in patients with ulcerative colitis.Marla C Dubinsky, Vipul Jairath, Brian G Feagan, April N Naegeli, Jay Tuttle
BMJ Open Gastroenterology. 2023-03-01 - 1 citationsCase Report: Nontuberculous mycobacterial infections in children with complete DiGeorge anomaly.Elizabeth Daly Hicks, Noah O Agada, Tyler R Yates, Matthew S Kelly, Jonathan S Tam
Frontiers in Immunology. 2023-01-01 - 11 citationsNo reactivation of tuberculosis in patients with latent tuberculosis infection receiving ixekizumab: A report from 16 clinical studies of patients with psoriasis or ps...Ulrich Mrowietz, Elisabeth Riedl, Stefan Winkler, Wen Xu, Himanshu Patel
Journal of the American Academy of Dermatology. 2020-06-08
Journal Articles
- Long‐Term Safety Profile of Ixekizumab in Patients with Moderate‐to‐Severe Plaque Psoriasis: An Integrated Analysis from 11 Clinical TrialsA B Kimball, N Agada, Journal of The European Academy of Dermatology and Venereology
Professional Memberships
- Member
- Member
- Member
External Links
- Carmel Allergyhttp://www.carmelallergy.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: